Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Rexahn Pharmaceuticals (RNN)

1.94 -0.02 (-1.02%)

12-14 16:00

Open:

1.96

Pre. Close:

1.96

High:

2

Low:

1.92

Volume:

144,565

Market Cap:

62M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

2.05 - 2.14

2.14 - 2.23

Low:

1.83 - 1.86

1.86 - 1.9

Close:

1.91 - 1.99

1.99 - 2.06

Technical analysis  (as of: 2017-12-14 4:57:10 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 2.56     One year: 2.77

Support:

Support1: 1.91    Support2: 1.59

Resistance:

Resistance1: 2.19    Resistance2: 2.37

Pivot:

2.10

Moving Averages:

MA(5): 2.00     MA(20): 2.10

MA(100): 2.16     MA(250): 1.70

MACD:

MACD(12,26): -0.03     Signal(12,26,9): -0.01

%K %D:

%K(14,3): 8.24     %D(3): 9.78

RSI:

RSI(14): 38.96

52-Week:

High: 4.74  Low: 0.13  Change(%): 1193.3

Average Vol(K):

3-Month: 51892  10-Days 21233

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
RNN has closed above bottom band by 11.7%. Bollinger Bands are 40.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to RNN's normal range. The bands have been in this narrow range for 12 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 17 Apr 2017 15:33:45 GMT
Could Rexahn Pharmaceuticals Have Something?

Tue, 05 Sep 2017 12:56:15 GMT
Rexahn Pharmaceuticals to Present at the 2017 Disruptive Growth Company ...

Mon, 11 Dec 2017 13:52:30 GMT
Rexahn Pharmaceuticals Presents New Preclinical Data on Supinoxin™ at the ...

Tue, 05 Sep 2017 12:56:15 GMT
Rexahn Pharmaceuticals to Present Updated Clinical and Preclinical Data at the ...

Tue, 29 Aug 2017 19:44:26 GMT
Rexahn Pharma up 27% on new US nanoparticle patent

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

31.73

Shares Float (M)

30.99

% Held by Insiders

2.31

% Held by Institutions

5.80

Shares Short (K)

2210

Shares Short Prior Month (K)

2110

Stock Financials

EPS

-0.870

EPS Est. Current Year

-1.280

EPS Est. Next Year

-0.680

EPS Est. Next Quarter

-0.250

Forward EPS

-0.549

Book Value (p.s.)

0.530

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-43.3

Return on Equity (ttm)

-137.4

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.515

Qtrly Earnings Growth

Operating Cash Flow (M)

-13.21

Levered Free Cash Flow (M)

-8.97

atoplab.com

Valuation

P/E

-2.23

P/E Growth Ratio

-0.01

P/BV

3.66

P/S

P/CF

-4.66

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2017-05-05

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.